Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maarten J Postma

Showing results (61-70 of 485) with videos related to

Pageof 49
Sort By:
JAMA|March 25, 2004
Cost-effectiveness of screening for proteinuriaRon T Gansevoort, Paul E de Jong, Maarten J Postma
BMC Public Health|December 12, 2019
Factors associated with the uptake of newly introduced childhood vaccinations in Ethiopia: the cases of rotavirus and pneumococcal conjugate vaccinesAbrham Wondimu, Qi Cao, Jan C Wilschut, et al.
Vaccine|May 28, 2013
Cost-effectiveness of rotavirus immunization in Indonesia: taking breastfeeding patterns into accountAuliya A Suwantika, Hong Anh T Tu, Maarten J Postma
Preventive Medicine Reports|July 7, 2022
Cost-effectiveness of a male catch-up human papillomavirus vaccination program in the NetherlandsJoost J M Simons, Tjalke A Westra, Maarten J Postma
International Journal for Equity in Health|November 25, 2025
Setting priorities for healthcare interventions in Indonesia: a comprehensive conceptual frameworkMohammed Alfaqeeh, Neily Zakiyah, Maarten J Postma, et al.
Pharmacoeconomics|December 21, 2004
Valuing prevention through economic evaluation: some considerations regarding the choice of discount model for health effects with focus on infectious diseasesJasper M Bos, Philippe Beutels, Lieven Annemans, et al.
The Journal of Mental Health Policy and Economics|May 17, 2013
The fiscal consequences of ADHD in Germany: a quantitative analysis based on differences in educational attainment and lifetime earningsNikolaos Kotsopoulos, Mark P Connolly, Esther Sobanski, et al.
International Journal of Chronic Obstructive Pulmonary Disease|October 6, 2016
Cost-effectiveness and budget impact of the fixed-dose dual bronchodilator combination tiotropium-olodaterol for patients with COPD in the NetherlandsJob Fm van Boven, Janwillem Wh Kocks, Maarten J Postma
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 27, 2017
The Fiscal Consequences Attributed to Changes in Morbidity and Mortality Linked to Investments in Health Care: A Government Perspective Analytic FrameworkMark P Connolly, Nikolaos Kotsopoulos, Maarten J Postma, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 15, 2011
Cost-effectiveness of lanthanum carbonate in the treatment of hyperphosphatemia in chronic kidney disease before and during dialysisStefan Vegter, Keith Tolley, Michael S Keith, et al.
Pageof 49

Showing results (61-70 of 485) with videos related to

Sort By:
Pageof 49
JAMA|March 25, 2004
Cost-effectiveness of screening for proteinuriaRon T Gansevoort, Paul E de Jong, Maarten J Postma
BMC Public Health|December 12, 2019
Factors associated with the uptake of newly introduced childhood vaccinations in Ethiopia: the cases of rotavirus and pneumococcal conjugate vaccinesAbrham Wondimu, Qi Cao, Jan C Wilschut, et al.
Vaccine|May 28, 2013
Cost-effectiveness of rotavirus immunization in Indonesia: taking breastfeeding patterns into accountAuliya A Suwantika, Hong Anh T Tu, Maarten J Postma
Preventive Medicine Reports|July 7, 2022
Cost-effectiveness of a male catch-up human papillomavirus vaccination program in the NetherlandsJoost J M Simons, Tjalke A Westra, Maarten J Postma
International Journal for Equity in Health|November 25, 2025
Setting priorities for healthcare interventions in Indonesia: a comprehensive conceptual frameworkMohammed Alfaqeeh, Neily Zakiyah, Maarten J Postma, et al.
Pharmacoeconomics|December 21, 2004
Valuing prevention through economic evaluation: some considerations regarding the choice of discount model for health effects with focus on infectious diseasesJasper M Bos, Philippe Beutels, Lieven Annemans, et al.
The Journal of Mental Health Policy and Economics|May 17, 2013
The fiscal consequences of ADHD in Germany: a quantitative analysis based on differences in educational attainment and lifetime earningsNikolaos Kotsopoulos, Mark P Connolly, Esther Sobanski, et al.
International Journal of Chronic Obstructive Pulmonary Disease|October 6, 2016
Cost-effectiveness and budget impact of the fixed-dose dual bronchodilator combination tiotropium-olodaterol for patients with COPD in the NetherlandsJob Fm van Boven, Janwillem Wh Kocks, Maarten J Postma
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 27, 2017
The Fiscal Consequences Attributed to Changes in Morbidity and Mortality Linked to Investments in Health Care: A Government Perspective Analytic FrameworkMark P Connolly, Nikolaos Kotsopoulos, Maarten J Postma, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 15, 2011
Cost-effectiveness of lanthanum carbonate in the treatment of hyperphosphatemia in chronic kidney disease before and during dialysisStefan Vegter, Keith Tolley, Michael S Keith, et al.
Pageof 49